Showing results (91-100 of 235) with videos related to
Sort By:
Pageof 24
European Neurology|October 12, 2012
Antibody-mediated status epilepticus: a retrospective multicenter surveyFranz Josef Holzer, Andrea O Rossetti, Anne-Chantal Heritier-Barras, et al.Journal of Neurochemistry|May 9, 2012
Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cellsCaroline Happold, Patrick Roth, Wolfgang Wick, et al.International Journal of Cancer|May 11, 2013
αv-Integrin isoform expression in primary human tumors and brain metastasesAlexander Vogetseder, Svenja Thies, Barbara Ingold, et al.Journal of Neurosurgery|December 8, 2009
Soluble CD70: a novel immunotherapeutic agent for experimental glioblastomaJames Miller, Guenter Eisele, Ghazaleh Tabatabai, et al.Journal of Neurochemistry|May 13, 2011
A specific miRNA signature in the peripheral blood of glioblastoma patientsPatrick Roth, Jörg Wischhusen, Caroline Happold, et al.Neuro-Oncology Practice|October 5, 2020
Antidepressant drug use in glioblastoma patients: an epidemiological viewDorothee Gramatzki, James Louis Rogers, Marian Christoph Neidert, et al.Science Translational Medicine|October 8, 2020
Immunocytokines are a promising immunotherapeutic approach against glioblastomaTobias Weiss, Emanuele Puca, Manuela Silginer, et al.Journal for Immunotherapy of Cancer|February 4, 2026
Potent antitumor activity through dual targeting of PD-L1 and TGF-β pathways in the glioma tumor microenvironmentManuela Silginer, Michael Weller, Burkhard Becher, et al.Multiple Sclerosis and Related Disorders|July 5, 2025
Treatment strategies of AQP4-IgG positive neuromyelitis optica spectrum disorder and MOG antibody-associated disorder in Switzerland: a nationwide surveyLukas Steinegger, Veronika Kana, Caroline Pot, et al.Acta Neuropathologica Communications|March 14, 2023
Immunological and tumor-intrinsic mechanisms mediate the synergistic growth suppression of experimental glioblastoma by radiotherapy and MET inhibitionManuela Silginer, Eleanna Papa, Emese Szabó, et al.Pageof 24